Felix Geissel graduated in 2015 with a bachelor’s degree in Nanotechnology from the University of Erlangen/Nuremberg, Germany. During that time, Felix spent five months in the group of Dr. Mikael Syväjärvi at Linköpings universitet to write his bachelor’s thesis about “3C-SiC and graphene heterostructures for new functionalities”. He continued moving to the UK and accomplishing his master’s degree in Biomaterials at the University of Manchester. The topic of his thesis was “Sol-gel synthesis of bioactive glass compositions for soft tissue regeneration”, supervised by Dr. Gowsh Poologasundarampilla. Felix is now using flame spray synthesis in order to manufacture nanosized multifunctional implant-coatings for osseointegration and antibacterial properties.
Anshika is currently a PhD student in our group focusing on the development of nanoparticles as nano-vaccines and bioimaging agents. She did her bachelors in biotech engineering from Indian institute of Technology, Roorkee. During her bachelor thesis she worked with various nanoparticle based composite antimicrobial agents. She completed an Erasmus Mundus joint master’s degree in Nanomedicine for drug delivery (EMJMD NANOMED). During her master’s she did a project with persistent luminescence nanoparticles. Anshika carried out her MSc thesis in our lab in the topic of luminescent/phosphorescent nanoparticles for diagnostics.
Shengtao is currently a PhD student in our group focusing on the development of nanoparticles as drug nanocarriers against lower respiratory tract infections. Shengtao received his BSc in Applied Chemistry from Kunming University of Science and Technology. During his undergraduate studies, he joined the organic synthesis group, where he focused on synthesizing 1,2,3-triazole derivatives. Following his undergraduate studies, he completed his MSc in pharmaceutical modelling at Uppsala University. His master’s thesis was utilizing MDS and machine learning techniques to better understand the behaviours of poorly water-soluble drugs in lipid-based formulations, supervised by Assoc. Prof. Larrson within the BLT group.